Curtis Triplitt

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

Y. Miyazaki, Leonard C. Glass, Curtis Triplitt et al. · Diabetologia · 2001 · 274 citations · Full text

Obesity, Metabolic Syndrome, Biochemistry +8

Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus

Yoshinori Miyazaki, Leonard C. Glass, Curtis Triplitt et al. · American Journal of Physiology-Endocrinology and Metabolism · 2002 · 255 citations

Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the <scp>E</scp> fficacy and <scp>D</scp> urability of <scp>I</scp> nitial <scp>C</scp> ombination <scp>T</scp> herapy for <scp>T</scp> ype 2 <scp>D</scp> iabetes ( <scp>EDICT</scp> ): a randomized trial

M. A. Abdul‐Ghani, Curtiss Puckett, Curtis Triplitt et al. · Diabetes Obesity and Metabolism · 2014 · 196 citations · Full text

Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes

Antonio Cervera, Estela Wajcberg, Apiradee Sriwijitkamol et al. · American Journal of Physiology-Endocrinology and Metabolism · 2008 · 157 citations

Nutrition, Insulin Signaling, Baseline Plasma Glucagon +16

Drug Interactions of Medications Commonly Used in Diabetes

Curtis Triplitt · Diabetes Spectrum · 2006 · 116 citations

Drug Safety, Drug Interactions, Medicinal Chemistry +15